TY  - GEN
AU  - Stevenson,James P
AU  - Rosen,Mark
AU  - Sun,Weijing
AU  - Gallagher,Maryann
AU  - Haller,Daniel G
AU  - Vaughn,David
AU  - Giantonio,Bruce
AU  - Zimmer,Ross
AU  - Petros,William P
AU  - Stratford,Michael
AU  - Chaplin,David
AU  - Young,Scott L
AU  - Schnall,Mitchell
AU  - O'Dwyer,Peter J
TI  - Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow
SN  - 0732-183X
PY  - 2004///0105
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Area Under Curve
KW  - Contrast Media
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - blood supply
KW  - Neovascularization, Pathologic
KW  - drug therapy
KW  - Stilbenes
KW  - Tomography, Emission-Computed
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2003.12.986
ER  -